Bukwang Pharmaceutical (003000) has 0 disclosed insider purchases and 0 disclosed disposals on record, filed by 0 distinct insiders. The earliest filing StockDrifts holds for Bukwang Pharmaceutical is dated 2025-06-16; the most recent is 2025-07-17.
| Date | Type | Source | Insider | Position | Shares | Price at filing | Return | Value |
|---|---|---|---|---|---|---|---|---|
| 2025-07-17 | BUY | 유상신주취득 | 권순일 Soonil Kwon | Managing Director | 582 | ₩3,645 | +47.3% | ₩2M ($1K) |
| 2025-07-17 | BUY | 유상신주취득 | OCI홀딩스 OCI Holdings | - | 9.1M | ₩3,645 | +47.3% | ₩33.3B ($23.1M) |
| 2025-07-17 | SELL | 기타 | 권순일 Soonil Kwon | Managing Director | -582 | ₩3,645 | -47.3% | ₩2M ($1K) |
| 2025-07-17 | SELL | 기타 | OCI홀딩스 OCI Holdings | - | -7.6M | ₩3,645 | -47.3% | ₩27.6B ($19.1M) |
| 2025-06-30 | SELL | 장외매도 | 김동연 Kim Dong-yeon | - | -2.5M | ₩3,670 | -46.3% | ₩9.1B ($6.3M) |
| 2025-06-30 | SELL | 장외매도 | 정창수 Changsoo Jeong | vice president | -2.1M | ₩3,670 | -46.3% | ₩7.8B ($5.4M) |
| 2025-06-30 | BUY | 장외매수 | OCI홀딩스 OCI Holdings | - | 4.8M | ₩3,670 | +46.3% | ₩17.7B ($12.3M) |
| 2025-06-16 | BUY | 기타 | 김동연 Kim Dong-yeon | - | 2.5M | ₩3,950 | +36.0% | ₩9.8B ($6.8M) |
| 2025-06-16 | BUY | 기타 | OCI홀딩스 OCI Holdings | - | 2.7M | ₩3,950 | +36.0% | ₩10.8B ($7.5M) |
| 2025-06-16 | BUY | 기타 | 권순일 Soonil Kwon | Managing Director | 582 | ₩3,950 | +36.0% | ₩2M ($2K) |
| 2025-06-16 | BUY | 기타 | 정창수 Changsoo Jeong | vice president | 2.1M | ₩3,950 | +36.0% | ₩8.4B ($5.9M) |
Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.